Clinical Trials
All Clinical Trials - Page 43 of 52
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT01373450Phase 1Completed
Evaluation of the Glucoregulatory Effects of Glucagon-like Peptide-1 Receptor (GLP-1 Receptor) Activation in Participants With Type 2 Diabetes Mellitus (MK-0000-222)
Liraglutide
- NCT01373216Phase 3Completed
Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
Exenatide
- NCT01336023Phase 3Completed
Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 Diabetes
Liraglutide
- NCT01410799Phase 2Terminated
Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
Sermorelin
- NCT02366208Phase 2Completed
Phase II Trial for Combination Treatment of PEG-Tα1 and Adefovir for HBeAg Positive Chronic Hepatitis B
Thymosin-Alpha-1
- NCT01257802Phase 3Terminated
GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases
Gonadorelin
- NCT01399645Phase 2Completed
Study of Liraglutide Versus Insulin on Liver Fat Fraction in Patients With Type 2 Diabetes
Liraglutide
- NCT00898326N/ACompleted
PSA Levels and Biopsy Samples After Implant Radiation and Hormone Therapy in Patients With Stage I or Stage II Prostate Cancer
Gonadorelin
- NCT01280344Phase 2Completed
Safety and Efficacy of Ipamorelin Compared to Placebo for the Recovery of Gastrointestinal Function
Ipamorelin
- NCT01344564N/ACompleted
Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide
Gonadorelin
- NCT01360840Phase 2Completed
EMD 525797 in Subjects With Asymptomatic or Mildly Symptomatic Metastatic Castrate-resistant Prostate Cancer
Gonadorelin
- NCT02292290Phase 4Completed
Trial for People With Established Type 2 Diabetes During Ramadan
Liraglutide
- NCT01296412Phase 3Completed
Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403)
Liraglutide
- NCT01302327N/AWithdrawn
GLP Analogs for Diabetes in Wolfram Syndrome Patients
Exenatide
- NCT01393132Phase 2Completed
Comparative Study of Thymosin Beta 4 Eye Drops vs. Vehicle in the Treatment of Severe Dry Eye
TB-500
- NCT01324505Phase 1Completed
Effect of Oral Contraceptives After Administration of Semaglutide in Subjects With Type 2 Diabetes
Semaglutide
- NCT01359488Phase 1Completed
VRS-317 in Adult Subjects With Growth Hormone Deficiency
Sermorelin
- NCT01319708Phase 1/Phase 2Completed
Mild Versus Conventional Ovarian Stimulation for Poor Responders Undergoing In Vitro Fertilisation
Gonadorelin
- NCT01319240Phase 1Completed
Safety and Tolerability of Insulin Degludec/Liraglutide (A3) in Healthy Subjects
Liraglutide
- NCT01575301N/ACompleted
DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
Liraglutide
- NCT01324388Phase 1Completed
A Study of the Effect of LY2189265 on Two Blood Pressure Drugs
Dulaglutide
- NCT01342042Phase 2Unknown
The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus
Exenatide
- NCT01817569N/ACompleted
Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)
Exenatide
- NCT01416649N/ACompleted
Impact of Exenatide on Sleep Duration
Exenatide
- NCT01288326N/ACompleted
Observational Study on Effectiveness and Safety of Liraglutide in Subjects With Type 2 Diabetes
Liraglutide
- NCT01300260Phase 1Completed
Effect of LY2189265 on Insulin Secretion in Response to Intravenous Glucose
Dulaglutide
- NCT01301092Phase 1Completed
A Study to Compare the Concentrations of LY2189265 After Different Methods of Administration to Healthy Volunteers.
Dulaglutide
- NCT01297062Phase 1Completed
A Safety Study to Assess the Effects of Therapeutic and Supratherapeutic Exenatide Concentrations on QT Interval in Healthy Subjects
Exenatide
- NCT01381926Phase 4Terminated
Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist
Exenatide
- NCT01272973Phase 1Completed
Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of NN9924 in Healthy Male Subjects
Semaglutide
- NCT02342197Phase 3Completed
Comparative Study Between Minidose Long Protocol and Microdose Flare Protocol in Controlled Ovarian Hyperstimulation
Gonadorelin
- NCT01599338N/ACompleted
Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic Patients
Liraglutide
- NCT01270789Phase 3Completed
LIraglutide and Beta-cell RepAir (LIBRA) Study
Liraglutide
- NCT01740921N/ACompleted
GLP-1 and Microvascular Function in Type 2 Diabetes
Liraglutide
- NCT02042664Phase 3Completed
Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics
Exenatide
- NCT01429506N/ACompleted
Efficacy of Laparoscopic Sleeve Gastrectomy and Intensive Medical Management in Obese Type 2 Diabetes
Exenatide
- NCT01263717N/ACompleted
Effects of Growth Hormone Releasing Hormone in HIV
Tesamorelin
- NCT01250834Phase 1Completed
LY2189265 and Atorvastatin Interaction Study
Dulaglutide
- NCT01269034Phase 4Completed
New Onset Type 1 Diabetes: Role of Exenatide
Exenatide
- NCT01269008Phase 1Completed
Closed Loop System With Pramlintide Versus Exenatide
Exenatide
- NCT01255163Phase 2Terminated
A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease
Exenatide
- NCT01240629Phase 1/Phase 2Completed
Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Gonadorelin
- NCT01132404Phase 1/Phase 2Terminated
Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448
Kisspeptin
- NCT01252693Phase 2Completed
International,Multi-Center,Open Label,Randomized Study Assessing the Safety and Efficacy of a Monthly Dosing Regimen of Ozarelix Versus Goserelin Depot in Men With Prostate Cancer
Gonadorelin
- NCT01212133N/ACompleted
A Post Marketing Surveillance (PMS) Study of Liraglutide in Subjects With Type 2 Diabetes Mellitus in India
Liraglutide
- NCT01695109Phase 4Completed
The Influence of Liraglutide on the Reward Properties of Food: an fMRI Study on Healthy Volunteers
Liraglutide
- NCT01191268Phase 3Completed
A Study in Participants With Type 2 Diabetes Mellitus (AWARD-4)
Dulaglutide
- NCT01253304Phase 1Completed
A Single Dose Study of LY2189265 in Subjects With Varying Degrees of Hepatic (Liver) Impairment
Dulaglutide
- NCT01235819Phase 4Completed
Comparison Between GLP 1 Analogues and DPP 4 Inhibitors in Type 1 Diabetes Mellitus
Exenatide
- NCT01237314N/ACompleted
The Impact of Food on Blood Sugar in People With Type 2 Diabetes
Exenatide